Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-26

Clinical Trial Update: Basket Study for Oligo-metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 basket trial evaluating therapies for oligo-metastatic HER2-positive breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: HER2-positive Breast Cancer | Phase 2 | Status: RECRUITING